Newron Pharmaceuticals S.p.A. (ETR:NP5)

Newron Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	219	95	28	28	35	104
Market Cap Growth	41.42%	239.07%	0.38%	-21.34%	-66.00%	17.33%
Enterprise Value	257	126	44	33	22	84
Last Close Price	10.98	5.30	1.51	1.53	1.98	5.80
PS Ratio	22.68	10.48	4.59	4.84	6.74	14.81
PB Ratio	-5.13	-3.17	-2.00	8.97	2.06	2.83
P/TBV Ratio	-	-	-	8.98	2.06	2.83
EV/Sales Ratio	35.95	13.95	7.26	5.77	4.13	11.93
Debt / Equity Ratio	-1.58	-1.62	-3.25	13.87	1.53	0.46
Asset Turnover	0.25	0.29	0.14	0.11	0.09	0.12
Quick Ratio	3.28	0.61	5.50	10.58	5.50	7.89
Current Ratio	3.73	0.68	5.65	10.79	5.50	8.13
Return on Equity (ROE)	-	-	-	-146.43%	-77.71%	-44.10%
Return on Assets (ROA)	-33.24%	-23.05%	-18.96%	-15.19%	-20.26%	-21.72%
Return on Capital (ROIC)	-42.51%	-28.99%	-21.37%	-17.20%	-23.21%	-24.01%
Earnings Yield	-8.59%	-17.09%	-62.50%	-53.44%	-59.23%	-19.38%
FCF Yield	-6.10%	-10.70%	-39.69%	-41.12%	-44.07%	-21.13%
Buyback Yield / Dilution	-2.01%	-	-	-	-	-0.01%
Total Shareholder Return	-2.01%	-	-	-	-	-0.01%

Source: S&P Capital IQ. Standard template. Financial Sources.